LOMBARD Medical Technologies may scale up operations at its manufacturing plant in Scotland after receiving approval from the US Food and Drug Administration (FDA) to launch a new product.
Aorfix – a flexible stent for use in vascular surgery – is not expected to be available in the US until the second half of this year.
Lombard Medical, which is based in Oxfordshire, said it will be business as usual at its Prestwick site until then but the new product could lead to a need to increase capacity.
We moderate all comments on HeraldScotland on either a pre-moderated or post-moderated basis. If you're a relatively new user then your comments will be reviewed before publication and if we know you well then your comments will be subject to moderation only if other users or the moderators believe you've broken the rules, which are available here.
Moderation is undertaken full-time 9am-6pm on weekdays, and on a part-time basis outwith those hours. Please be patient if your posts are not approved instantly.
